数据链接：
官方服务：
资源简介：
Sensitivity of sarcoma cell lines to LLL12.
应用场景：
创建时间：
2015-12-02
相关数据集
MOESM5 of Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
Additional file 5: Table S4. Tumor type-specific drug associations identified using 37-drug library. Wilcoxon rank sum test was applied to determine the relative differences of drug sensitivity betwee
Figshare2024-02-15 更新50
Differences and significance at lowest tested concentration (LTC) and clinically achievable concentration (CAC) in numbers of logs of cell kill between p53 non-functional vs. functional cell lines, between p16/14 null vs. wild lines, and between lines established at diagnosis vs. those established at PD or post-chemo.
Differences and significance at lowest tested concentration (LTC) and clinically achievable concentration (CAC) in numbers of logs of cell kill between p53 non-functional vs. functional cell lines, be
NIAID Data Ecosystem30
IC50 values for medulloblastoma and glioblastoma cell lines.
The half-maximal inhibitory concentrations (IC50) calculated for LLL12 and other STAT3/JAK2 inhibitors (µM) in medulloblastoma and glioblastoma cell lines. Cellular proliferation was measured using a
Figshare2015-12-02 更新30
16 prostatic cancer cell lines and sensitivity to an anticancer tumor agent dasatinib
Transcriptional profiling was conducted on RNA from 16 prostatic cancer cell lines to identify genes whose expression level correlate with sensitivity of an anti-tumor agent (dasatinib). Keywords: com
NIAID Data Ecosystem40
IC 50 of RTKIs for NSCLC cell lines with and without T790M mutation.
IC50 of RTKIs for NSCLC cell lines with and without T790M mutation.
NIAID Data Ecosystem30
